A growing number of laboratories around the world are using Vircell Extraction & Amplification controls for PCR QC purposes; to comply with lab accreditation and to improve patient care.
We would like to share with you a recent publication on the benefits of the Vircell VirClia analyser written by Jamie Laughlin, Head of Operations at the South West London Pathology (SWLP), St George’s University Hospitals NHS Foundation Trust, UK.
The Virclia® system it is a small automated platform that will serve as the ideal complementary system for those esoteric and low volume tests. To improve turn around time and the efficiency in your laboratory.
Vircell have added eight new references to the extensive diagnostic VirClia® panel, with more than 80 products:
It’s time to welcome the New Vircell VirClia® Plus!
In light of the latest developments in molecular diagnosis towards multiplex testing, Vircell has taken the decision to discontinue some of their older products to better adapt to the current offer of PCR kits in the market.
Infections caused by arthropod-borne-viruses (arbovirus) are a major cause of hospitalization. Dengue (serotypes 1, 2, 3 and 4), Zika virus and chikungunya are arboviruses that produce similar clinical presentations.
Certify the efficiency, quality and reliability of your molecular infectious disease testing. The AmpliRun® DNA/RNA Amplification Controls contain the purified complete genome of the infectious agent.
It is a pleasure to inform you that Vircell have increased the concentration of each pathogen of the AmpliRun® Total controls, ranging now from 20 to 50 copies/µl.